Allogene Therapeutics
Earnings Surprise
Analysts estimated ALLO earnings of $-0.22 per share this quarter (Q4). ALLO's actual earnings were $-0.17 per share.
ALLO EPS surprise of 22.97%Analysts estimated ALLO earnings of $-0.23 per share this quarter (Q3). ALLO's actual earnings were $-0.19 per share.
ALLO EPS surprise of 16.56%Analysts estimated ALLO earnings of $-0.28 per share this quarter (Q2). ALLO's actual earnings were $-0.23 per share.
ALLO EPS surprise of 17.56%Analysts estimated ALLO earnings of $-0.30 per share this quarter (Q1). ALLO's actual earnings were $-0.28 per share.
ALLO EPS surprise of 5.25%Analysts estimated ALLO earnings of $-0.34 per share this quarter (Q4). ALLO's actual earnings were $-0.28 per share.
ALLO EPS surprise of 17.65%Analysts estimated ALLO earnings of $-0.35 per share this quarter (Q2). ALLO's actual earnings were $-0.32 per share.
ALLO EPS surprise of 9.68%Analysts estimated ALLO earnings of $-0.42 per share this quarter (Q1). ALLO's actual earnings were $-0.38 per share.
ALLO EPS surprise of 8.98%Analysts estimated ALLO earnings of $-0.46 per share this quarter (Q4). ALLO's actual earnings were $-0.43 per share.
ALLO EPS surprise of -6.13%Analysts estimated ALLO earnings of $-0.53 per share this quarter (Q3). ALLO's actual earnings were $-0.37 per share.
ALLO EPS surprise of -30.18%